Everett Harris & Co. CA Boosts Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Everett Harris & Co. CA boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 28.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,987 shares of the company's stock after acquiring an additional 13,847 shares during the quarter. Everett Harris & Co. CA's holdings in Bath & Body Works were worth $2,442,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. True Wealth Design LLC raised its position in Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock worth $34,000 after buying an additional 1,054 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its position in Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock valued at $38,000 after purchasing an additional 900 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in Bath & Body Works in the third quarter worth approximately $39,000. Finally, TD Private Client Wealth LLC raised its stake in Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock valued at $54,000 after buying an additional 331 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

BBWI stock traded down $0.18 during midday trading on Wednesday, reaching $38.61. The company's stock had a trading volume of 928,257 shares, compared to its average volume of 2,909,497. The firm has a market capitalization of $8.36 billion, a price-to-earnings ratio of 9.41, a PEG ratio of 1.01 and a beta of 1.83. The stock has a fifty day simple moving average of $37.67 and a two-hundred day simple moving average of $33.61. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to analysts' expectations of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company's revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.48 EPS. As a group, analysts forecast that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date was Friday, November 22nd. Bath & Body Works's dividend payout ratio (DPR) is presently 19.51%.

Analysts Set New Price Targets

Several analysts recently commented on the company. Wells Fargo & Company raised Bath & Body Works from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $42.00 to $48.00 in a report on Friday, January 10th. TD Cowen raised their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, December 12th. Morgan Stanley decreased their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating on the stock in a research report on Thursday, November 21st. Argus restated a "hold" rating on shares of Bath & Body Works in a research note on Friday, January 10th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and issued a $42.00 target price on shares of Bath & Body Works in a report on Monday, November 25th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $43.19.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.